Holen Sie sich die Stockscreener-App
127.65
0.24%
0.30
Handel nachbörslich:
127.77
0.12
+0.09%
Schlusskurs vom Vortag:
$127.35
Offen:
$127.29
24-Stunden-Volumen:
8.91M
Relative Volume:
0.88
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.68%
1M Leistung:
+5.04%
6M Leistung:
+48.55%
1J Leistung:
+39.63%
1-Tages-Spanne:
$125.98
$129.70
1-Wochen-Bereich:
$123.79
$129.70
52-Wochen-Spanne:
$66.66
$132.09
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XBI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
127.65 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
339.85 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
689.53 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
692.57 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
272.22 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
616.52 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
4,441 Shares in SPDR S&P Telecom ETF $XTL Purchased by Arkadios Wealth Advisors - Defense World
These Three Biotechs Have the Right Mix as the Industry Gains - TheStreet Pro
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Biotech ETF (XBI) Hits New 52-Week High - TradingView
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg
Stock Market Today: Dow gains 250 points, S&P 500 and Nasdaq advance after Trump’s Greenland pivot boosts risk appetite - MarketWatch
Moderna Stock Explodes To New 52-Week High: What's Driving The Action? - Benzinga
2025 ETF Wrap-Up And What To Expect In 2026 - Seeking Alpha
Should you invest in the State Street SPDR S&P Biotech ETF (XBI)? - MSN
U.S. Biotech Rebound in 2026: IPOs, Deals & Policy Clarity Drive OptimismNews and Statistics - IndexBox
Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84% - Intellectia AI
US Biotech Share Sales Deliver Biggest First Week Since 2021 - Bloomberg
‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Equity Markets Rally, Commodities Decline as ETF Investors Optimize Portfolios for 2026 - Bitget
Equities Surge, Commodities Sink As ETF Investors Plan 2026Vanguard S&P 500 ETF (ARCA:VOO) - Benzinga
As Artificial Intelligence Stocks Surge in Value, Health Care ETFs Take Center Stage for Growth - Bitget
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Biotech and pharma stocks tumble as investors race into energy - MSN
Biotech and Pharma Stocks Tumble as Investors Race into Energy - Barron's
Biotech: Time For A Pause To Start 2026 - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - sharewise.com
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Chart of the Week: Moderna Stock May Be Finding a Bottom - Barron's
2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood - Seeking Alpha
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - MSN
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
Look What I Found While Bargain Hunting in the Biotech Sector - TheStreet Pro
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026 - Benzinga
If You Invested $100 In State Street SPDR S&P Biotech ETF Stock 20 Years Ago, You Would Have This Much Today - Benzinga
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
Why Is Trinity Biotech Stock Soaring Tuesday? - Benzinga
Toast, Uber And More On CNBC's 'Final Trades'Baidu (NASDAQ:BIDU), Lyft (NASDAQ:LYFT) - Benzinga
If These Biotech Stocks Pull Back, I'll Be Ready to Pull the Trigger - TheStreet Pro
Biotech Was ‘En Fuego’ — Now I've Got My Eyes on Another Market Laggard - TheStreet Pro
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? - MSN
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
I'm Eyeing One Big, One Little Biotech for a Repeat Trade - TheStreet Pro
Should You Invest in the iShares Biotechnology ETF (IBB)? - sharewise.com
Should State Street SPDR MSCI USA StrategicFactors ETF (QUS) be on your investing radar? - MSN
2 Brilliant Biotech ETFs to Watch in 2026 - AOL.com
Biotech ETFs Gain Momentum with Promising Gains and Risks - cointurk finance
Should you invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - MSN
Should State Street SPDR S&P Dividend ETF (SDY) be on your investing radar? - MSN
Should You Invest in the SPDR S&P Homebuilders ETF (XHB)? - MSN
Eight stock picks to play one of the healthiest corners of the market - MarketWatch
Opinion: The Fed cut rates. Biotech didn’t notice. - MarketWatch
3 Undervalued ETFs to Buy Before 2026 - Yahoo Finance
Should you invest in the State Street SPDR S&P Software & Services ETF (XSW)? - MSN
Biotech ETF (XBI) hits new 52-week high - MSN
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):